Literature DB >> 15254756

Peptide nucleic acid-DNA decoy chimeras targeting NF-kappaB transcription factors: Induction of apoptosis in human primary osteoclasts.

Letizia Penolazzi1, Monica Borgatti, Elisabetta Lambertini, Carlo Mischiati, Alessia Finotti, Alessandra Romanelli, Michele Saviano, Carlo Pedone, Roberta Piva, Roberto Gambari.   

Abstract

Peptide nucleic acids (PNAs) are DNA mimics constituted by a pseudopeptide backbone composed of N-(2-aminoethyl)glycine units. PNAs hybridize with high affinity to complementary sequences of single-stranded RNA and DNA, forming Watson-Crick double helices and are resistant to both nucleases and proteases. While applications of PNAs as antisense and antigene molecules have been described, PNA/DNA and PNA/PNA hybrids are not useful for transcription factor decoy (TFD) pharmacotherapy. By contrast, PNA-DNA-PNA (PDP) chimeras, constituted of sequential PNA, DNA and PNA stretches, are potent decoy molecules in vitro. Interestingly, PDP-based decoys a) are more soluble than PNAs, b) are more resistant than synthetic oligonucleotides to enzymatic activity present in cellular extracts and serum and c) can be delivered with liposomes. In the present study we demonstrated that double-stranded PNA-DNA-PNA chimeras targeting NF-kappaB transcription factors induce apoptosis of human primary osteoclasts. Our data suggest that PDP-based induction of osteoclast apoptosis could be a therapeutic approach for disorders in which bone resorption is inappropriately excessive.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15254756

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  4 in total

1.  Effects of decoy molecules targeting NF-kappaB transcription factors in Cystic fibrosis IB3-1 cells: recruitment of NF-kappaB to the IL-8 gene promoter and transcription of the IL-8 gene.

Authors:  Alessia Finotti; Monica Borgatti; Valentino Bezzerri; Elena Nicolis; Ilaria Lampronti; Maria Dechecchi; Irene Mancini; Giulio Cabrini; Michele Saviano; Concetta Avitabile; Alessandra Romanelli; Roberto Gambari
Journal:  Artif DNA PNA XNA       Date:  2012-04-01

Review 2.  Anti-RANKL therapy for bone tumours: Basic, pre-clinical and clinical evidences.

Authors:  Dominique Heymann
Journal:  J Bone Oncol       Date:  2012-04-26       Impact factor: 4.072

3.  The role of the P2X7 receptor on bone loss in a mouse model of inflammation-mediated osteoporosis.

Authors:  T M Kvist; S Syberg; S Petersen; M Ding; N R Jørgensen; P Schwarz
Journal:  Bone Rep       Date:  2015-10-23

4.  Induction of endogenous gamma-globin gene expression with decoy oligonucleotide targeting Oct-1 transcription factor consensus sequence.

Authors:  Xiaoxin S Xu; Xin Hong; Gan Wang
Journal:  J Hematol Oncol       Date:  2009-03-27       Impact factor: 17.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.